Get the Stockscreener App
3.765
2.03%
0.075
Briacell Therapeutics Corp Stock (BCTX) Forecast
The Briacell Therapeutics Corp (BCTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $32.97, representing a +775.77% increase from the current price of $3.765. The highest analyst price target is $55.03, and the lowest is $10.92.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCTX Price Target
Average 41.92
(+1,013% Upside)
Is Briacell Therapeutics Corp (BCTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.79 | Neutral |
| STOCH(9,6) | 6.6959 | Buy |
| STOCHRSI(14) | 15.72 | Buy |
| MACD(12,26) | -0.0113 | Sell |
| ADX(14) | 21.92 | Neutral |
| William %R | -86.99 | Buy |
| CCI(14) | -89.56 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.9105
Sell
|
3.8735
Sell
|
| MA20 |
4.0392
Sell
|
3.9134
Sell
|
| MA50 |
3.7966
Sell
|
3.8314
Sell
|
| MA100 |
3.5753
Buy
|
3.8573
Sell
|
| MA200 |
4.0345
Sell
|
4.3253
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BCTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on BCTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.79 indicates that BCTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 6.6959 indicates that BCTX is oversold. This indicates that BCTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 15.72 indicates that BCTX is oversold. This suggests that BCTX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.92 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -89.56 indicates that BCTX is still oversold but not to an extreme extent.
Long-term BCTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Briacell Therapeutics Corp financial reports and earnings history, Briacell Therapeutics Corp (BCTX) stock could reach $35.96 by 2030, $125.75 by 2040 and $398.34 by 2050. See the projected annual prices until 2050 of the Briacell Therapeutics Corp stock below:
- Briacell Therapeutics Corp (BCTX) is expected to reach an average price of $59.77 in 2035, with a high prediction of $56.27 and a low estimate of $61.33. This indicates an $1,487% rise from the last recorded price of $3.765.
- Briacell Therapeutics Corp (BCTX) stock is projected to chart a bullish course in 2040, with an average price target of $117.78, representing an $3,028% surge from its current level. The forecast ranges from a conservative $120.47 to a sky-high $125.75.
- Our analysts predict Briacell Therapeutics Corp (BCTX) to jump 6,452% by 2045, soaring from $250.26 to an average price of $246.68, potentially reaching $251.42. While $250.26 is the low estimate, the potential upside is significant.
- Briacell Therapeutics Corp (BCTX) stock is expected to climb by 2050, reaching an average of $402.84, a $10,600% jump from its current level. However, a wide range of estimates exists, with high and low targets of $398.34 and $388.88, respectively, highlighting the market's uncertainty.
Briacell Therapeutics Corp Stock (BCTX) Year by Year Forecast
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2026
The predicted value for Briacell Therapeutics Corp (BCTX) in 2026 is set at an average of $41.02. Estimates vary from a peak of $81.98 to a trough of $0.0672, indicating an +989.61% surge from the present price of $3.765.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $42.18 | $10.92 | $55.03 | +1,020% |
| December, 2026 | $35.49 | $1.5347 | $81.98 | +842.55% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Briacell Therapeutics Corp (BCTX) is $41.92, with a high forecast of $83.68 and a low forecast of $0.1589. This indicates an +1,013% increase from the last price of $3.765.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.7957 | $3.4457 | $40.19 | +27.38% |
| February, 2027 | $12.20 | $2.944 | $21.50 | +224.16% |
| March, 2027 | $27.17 | $0.1589 | $29.42 | +621.53% |
| April, 2027 | $57.22 | $17.32 | $58.72 | +1,420% |
| May, 2027 | $7.1648 | $2.417 | $83.68 | +90.30% |
| June, 2027 | $19.71 | $22.86 | $17.91 | +423.40% |
| July, 2027 | $0.00278 | $12.05 | $12.75 | -99.93% |
| August, 2027 | $5.0637 | $1.9863 | $8.3637 | +34.50% |
| September, 2027 | $15.77 | $1.6674 | $17.12 | +318.93% |
| October, 2027 | $32.18 | $10.72 | $36.68 | +754.75% |
| November, 2027 | $12.04 | $1.1643 | $35.83 | +219.85% |
| December, 2027 | $0.4011 | $0.8055 | $15.09 | -89.35% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2028
In 2028, Briacell Therapeutics Corp (BCTX) is projected to reach an average price of $22.81, with a high projection of $45.06 and a low estimate of $0.5581. This indicates an +505.77% rise from the last price of $3.765.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.988 | $3.3424 | $8.8532 | -73.76% |
| February, 2028 | $16.98 | $0.5581 | $10.83 | +350.97% |
| March, 2028 | $32.13 | $1.5748 | $36.18 | +753.38% |
| April, 2028 | $30.84 | $19.59 | $41.79 | +719.08% |
| May, 2028 | $27.35 | $12.95 | $36.74 | +626.41% |
| June, 2028 | $31.46 | $21.40 | $39.36 | +735.54% |
| July, 2028 | $18.67 | $10.87 | $38.86 | +395.86% |
| August, 2028 | $19.63 | $11.42 | $27.58 | +421.32% |
| September, 2028 | $24.64 | $12.23 | $29.68 | +554.36% |
| October, 2028 | $29.70 | $18.94 | $35.70 | +688.78% |
| November, 2028 | $39.06 | $26.91 | $45.06 | +937.35% |
| December, 2028 | $13.92 | $13.17 | $40.46 | +269.59% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2029
The 2029 price forecast for Briacell Therapeutics Corp Stock (BCTX) is $20.39 on average, with a high prediction of $39.43 and a low estimate of $1.3388. This represents an +441.46% increase from the previous price of $3.765.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.7739 | $5.3717 | $28.37 | +133.04% |
| February, 2029 | $1.0349 | $6.0151 | $2.9849 | -72.51% |
| March, 2029 | $7.9937 | $1.4629 | $20.89 | +112.32% |
| April, 2029 | $4.8047 | $2.7047 | $28.15 | +27.61% |
| May, 2029 | $1.2866 | $1.3388 | $8.4569 | -65.83% |
| June, 2029 | $6.3278 | $2.2844 | $5.9656 | +68.07% |
| July, 2029 | $13.57 | $7.1756 | $12.37 | +260.34% |
| August, 2029 | $22.51 | $15.61 | $19.51 | +497.82% |
| September, 2029 | $32.80 | $21.60 | $20.96 | +771.16% |
| October, 2029 | $33.96 | $32.61 | $30.94 | +802.08% |
| November, 2029 | $38.63 | $36.18 | $35.81 | +926.02% |
| December, 2029 | $40.33 | $39.10 | $39.43 | +971.12% |
Briacell Therapeutics Corp Stock (BCTX) Price Forecast for 2030
Briacell Therapeutics Corp Stock (BCTX) is expected to reach an average price of $32.31 in 2030, with a high forecast of $37.06 and a low forecast of $27.55. This signifies an +758.06% surge from the last price of $3.765.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $38.90 | $37.49 | $35.96 | +933.26% |
| February, 2030 | $31.14 | $32.95 | $37.06 | +727.04% |
| March, 2030 | $32.29 | $31.75 | $30.99 | +757.75% |
| April, 2030 | $28.00 | $32.44 | $32.68 | +643.57% |
| May, 2030 | $32.99 | $28.85 | $32.33 | +776.11% |
| June, 2030 | $34.24 | $32.47 | $33.67 | +809.53% |
| July, 2030 | $33.73 | $33.81 | $34.05 | +795.95% |
| August, 2030 | $32.27 | $33.04 | $33.71 | +757.21% |
| September, 2030 | $30.69 | $31.23 | $32.12 | +715.22% |
| October, 2030 | $30.46 | $30.01 | $29.62 | +709.14% |
| November, 2030 | $28.73 | $28.93 | $30.00 | +662.96% |
| December, 2030 | $27.49 | $27.55 | $28.22 | +630.26% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):